Hit-to-Lead


Weill Medical College of Cornell University, NIAID, NIH, DHHS
The Broad Institute
GlaxoSmithKline
Rutgers University
TB Alliance, University of Auckland
TB Alliance, University of Auckland
Aston University, University of Birmingham, Tres Cantos GSK
University of Illinois at Chicago, Myongji University
Colorado State University
Lilly TB Drug Discovery Initative
Texas A&M University
University of Illinois at Chicago
GlaxoSmithKline, TB Alliance
TB Alliance, Sanofi
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)

Lead Optimization


CSIR-Institute for Microbial Technology (IMTech), Johnson & Johnson
Texas A&M University
São Paulo State University (UNESP)
GlaxoSmithKline
Calibr, The Scripps Research Institute
TB Alliance
GlaxoSmithKline, Anacor Pharmaceuticals
SPRINT TB (National University of Singapore)
Kanury Rao, Sundeep Duggar
GlaxoSmithKline, TB Alliance
Sequella
Sanofi , TB Alliance
TB Alliance/Yonsei University
SPRINT-TB (National University of Singapore)
TB Alliance, Sanofi
SPRINT-TB (National University of Singapore)

Pre-Clinical (Non-GLP)


Guangzhou Egg Biotechnology Co., Ltd.
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan, Lilly TB Drug Discovery Initiative, NIAID, IDRI, Lilly, YourEncore